{"id":"https://openalex.org/W1964486259","doi":"https://doi.org/10.1182/blood-2010-09-305847","title":"Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies","display_name":"Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies","publication_year":2011,"publication_date":"2011-03-29","ids":{"openalex":"https://openalex.org/W1964486259","doi":"https://doi.org/10.1182/blood-2010-09-305847","mag":"1964486259","pmid":"https://pubmed.ncbi.nlm.nih.gov/21444918"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2010-09-305847","doi":"https://doi.org/10.1182/blood-2010-09-305847","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2010-09-305847","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016538112","display_name":"Gerhard J. Niederfellner","orcid":"https://orcid.org/0000-0001-5487-2929","observed_orcids":["https://orcid.org/0000-0001-5487-2929"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gerhard Niederfellner","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041686856","display_name":"Alfred Lammens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Alfred Lammens","raw_affiliation_strings":["Department of Chemistry and Biochemistry, Gene Center, Ludwig-Maximilians Universit\u00e4t, Munich, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, Gene Center, Ludwig-Maximilians Universit\u00e4t, Munich, Germany;","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023182732","display_name":"Olaf Mundigl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olaf Mundigl","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058855855","display_name":"Guy J. Georges","orcid":"https://orcid.org/0000-0001-5737-006X","observed_orcids":["https://orcid.org/0000-0001-5737-006X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guy J. Georges","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112329656","display_name":"Wolfgang M. Sch\u00e4fer","orcid":"https://orcid.org/0000-0002-0764-0372","observed_orcids":["https://orcid.org/0000-0002-0764-0372"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Schaefer","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103726627","display_name":"Manfred Schwaiger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manfred Schwaiger","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andreas Franke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Franke","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053991660","display_name":"Kornelius Wiechmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kornelius Wiechmann","raw_affiliation_strings":["Institut f\u00fcr Chemie und Biochemie, Freie Universit\u00e4t, Berlin, Germany;","Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Chemie und Biochemie, Freie Universit\u00e4t, Berlin, Germany;","institution_ids":["https://openalex.org/I75951250"]},{"raw_affiliation_string":"Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061077016","display_name":"Stefan Jenewein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Jenewein","raw_affiliation_strings":["Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007630396","display_name":"Jerry W. Slootstra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153255","display_name":"Pepscan (Netherlands)","ror":"https://ror.org/03veq6934","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210153255"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jerry W. Slootstra","raw_affiliation_strings":["Pepscan Therapeutics BV, Lelystad, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pepscan Therapeutics BV, Lelystad, The Netherlands;","institution_ids":["https://openalex.org/I4210153255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077088234","display_name":"Peter Timmerman","orcid":"https://orcid.org/0000-0001-6687-5297","observed_orcids":["https://orcid.org/0000-0001-6687-5297"]},"institutions":[{"id":"https://openalex.org/I4210153255","display_name":"Pepscan (Netherlands)","ror":"https://ror.org/03veq6934","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210153255"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter Timmerman","raw_affiliation_strings":["Pepscan Therapeutics BV, Lelystad, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pepscan Therapeutics BV, Lelystad, The Netherlands;","institution_ids":["https://openalex.org/I4210153255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066911275","display_name":"Annika Br\u00e4nnstr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annika Br\u00e4nnstr\u00f6m","raw_affiliation_strings":["Sidec AB, Kista, Sweden; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidec AB, Kista, Sweden; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022923722","display_name":"Frida Lindstrom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frida Lindstrom","raw_affiliation_strings":["Sidec AB, Kista, Sweden; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidec AB, Kista, Sweden; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013172296","display_name":"Ekkehard M\u00f6ssner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ekkehard M\u00f6ssner","raw_affiliation_strings":["Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040318787","display_name":"Pablo Uma\u00f1a","orcid":"https://orcid.org/0000-0001-8206-2771","observed_orcids":["https://orcid.org/0000-0001-8206-2771"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Pablo Umana","raw_affiliation_strings":["Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063163809","display_name":"Karl\u2010Peter Hopfner","orcid":"https://orcid.org/0000-0002-4528-8357","observed_orcids":["https://orcid.org/0000-0002-4528-8357"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Karl-Peter Hopfner","raw_affiliation_strings":["Department of Chemistry and Biochemistry, Gene Center, Ludwig-Maximilians Universit\u00e4t, Munich, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, Gene Center, Ludwig-Maximilians Universit\u00e4t, Munich, Germany;","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067162282","display_name":"Christian Klein","orcid":"https://orcid.org/0000-0001-7594-7280","observed_orcids":["https://orcid.org/0000-0001-7594-7280"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christian Klein","raw_affiliation_strings":["Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5016538112","https://openalex.org/A5041686856"],"corresponding_institution_ids":["https://openalex.org/I8204097"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":13.7442,"has_fulltext":false,"cited_by_count":229,"citation_normalized_percentile":{"value":0.9943081,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"118","issue":"2","first_page":"358","last_page":"367"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.03370000049471855,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.9300000071525574},{"id":"https://openalex.org/keywords/obinutuzumab","display_name":"obinutuzumab","score":0.9570000171661377},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/epitope-mapping","display_name":"epitope mapping","score":0.8090000152587891},{"id":"https://openalex.org/keywords/fab-fragment","display_name":"Fab fragment","score":0.7379999756813049},{"id":"https://openalex.org/keywords/cyclopeptides","display_name":"cyclopeptides","score":0.8080000281333923},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5956434607505798},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5353928208351135},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.47816401720046997},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3849494159221649},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3591731786727905},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32408517599105835},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23623532056808472}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016297","descriptor_name":"Mutagenesis, Site-Directed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017433","descriptor_name":"Protein Structure, Secondary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018604","descriptor_name":"Epitope Mapping","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D020836","descriptor_name":"Protein Structure, Quaternary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1182/blood-2010-09-305847","doi":"https://doi.org/10.1182/blood-2010-09-305847","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2010-09-305847","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:21444918","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21444918","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:dare.uva.nl:openaire_cris_publications/bf0277ad-aa73-4eee-9511-5abfb6b1aac5","doi":null,"is_oa":false,"landing_page_url":"https://handle.uba.uva.nl/personal/pure/en/publications/epitope-characterization-and-crystal-structure-of-ga101-provide-insights-into-the-molecular-basis-for-type-iii-distinction-of-cd20-antibodies(bf0277ad-aa73-4eee-9511-5abfb6b1aac5).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400088","display_name":"UvA-DARE (University of Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887064364","host_organization_name":"University of Amsterdam","host_organization_lineage":["https://openalex.org/I887064364"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Niederfellner, G, Lammens, A, Mundigl, O, Georges, G J, Schaefer, W, Schwaiger, M, Franke, A, Wiechmann, K, Jenewein, S, Slootstra, J W, Timmerman, P, Br\u00e4nnstr\u00f6m, A, Lindstrom, F, M\u00f6ssner, E, Umana, P, Hopfner, K P & Klein, C 2011, 'Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies', Blood, vol. 118, no. 2, pp. 358-367. https://doi.org/10.1182/blood-2010-09-305847","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dora:psi_13743","doi":null,"is_oa":false,"landing_page_url":"https://www.dora.lib4ri.ch/psi/item/psi:13743","pdf_url":null,"source":{"id":"https://openalex.org/S4306402574","display_name":"DORA PSI (Paul Scherrer Institute)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2802229908","host_organization_name":"Paul Scherrer Institute","host_organization_lineage":["https://openalex.org/I2802229908"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uvapub:oai:dare.uva.nl:publications/bf0277ad-aa73-4eee-9511-5abfb6b1aac5","doi":null,"is_oa":false,"landing_page_url":"https://dare.uva.nl/personal/pure/en/publications/epitope-characterization-and-crystal-structure-of-ga101-provide-insights-into-the-molecular-basis-for-type-iii-distinction-of-cd20-antibodies(bf0277ad-aa73-4eee-9511-5abfb6b1aac5).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 118(2), 358 - 367. American Society of Hematology","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322463","display_name":"Paul Scherrer Institut","ror":"https://ror.org/03eh3y714"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1973919081","https://openalex.org/W1977422931","https://openalex.org/W1977932880","https://openalex.org/W1994042177","https://openalex.org/W1996710470","https://openalex.org/W2027374210","https://openalex.org/W2043252724","https://openalex.org/W2061766263","https://openalex.org/W2065900855","https://openalex.org/W2067685415","https://openalex.org/W2069207490","https://openalex.org/W2091057822","https://openalex.org/W2094854089","https://openalex.org/W2122725450","https://openalex.org/W2159970259","https://openalex.org/W6641762050"],"related_works":["https://openalex.org/W2563206354","https://openalex.org/W2042725832","https://openalex.org/W2979462099","https://openalex.org/W2560361367","https://openalex.org/W4205274663","https://openalex.org/W2791833398","https://openalex.org/W7096895820","https://openalex.org/W2135802989","https://openalex.org/W3048370294","https://openalex.org/W2109687784"],"abstract_inverted_index":{"CD20":[0,25,85,94,127,141,165],"is":[1,110],"a":[2,12,68,84,96,131,170],"cell-surface":[3],"marker":[4],"of":[5,21,39,49,67,108,125,159,162],"normal":[6],"and":[7,80,152,183],"malignant":[8,22,41],"B":[9,42],"cells.":[10,43],"Rituximab,":[11],"monoclonal":[13],"antibody":[14,71],"targeting":[15],"CD20,":[16],"has":[17],"improved":[18],"the":[19,46,54,63,74,105,149,163,175],"treatment":[20],"lymphomas.":[23],"Therapeutic":[24],"antibodies":[26],"are":[27],"classified":[28],"as":[29],"either":[30],"type":[31,69,101,116,181],"I":[32,102,117,182],"or":[33,134],"II":[34,70,184],"based":[35],"on":[36],"different":[37,98,122,140,156,176],"mechanisms":[38],"killing":[40],"To":[44],"reveal":[45],"molecular":[47,172],"basis":[48],"this":[50],"distinction,":[51],"we":[52],"fine-mapped":[53],"epitopes":[55],"recognized":[56],"by":[57,72,180],"both":[58],"types.":[59],"We":[60],"also":[61],"determined":[62],"first":[64],"X-ray":[65],"structure":[66],"crystallizing":[73],"obinutuzumab":[75],"(GA101)":[76],"Fab":[77],"fragment":[78],"alone":[79],"in":[81,95,115,121],"complex":[82],"with":[83,148],"cyclopeptide.":[86],"Despite":[87],"recognizing":[88],"an":[89],"overlapping":[90],"epitope,":[91],"GA101":[92,109,133],"binds":[93],"completely":[97],"orientation":[99],"than":[100,114],"antibodies.":[103,185],"Moreover,":[104],"elbow":[106],"angle":[107],"almost":[111],"30\u00b0":[112],"wider":[113],"antibodies,":[118,151],"potentially":[119],"resulting":[120],"spatial":[123],"arrangements":[124],"2":[126,150],"molecules":[128],"bound":[129],"to":[130,145],"single":[132],"rituximab":[135],"molecule.":[136],"Using":[137],"protein":[138],"tomography,":[139],"complexes":[142],"were":[143],"found":[144],"be":[146],"associated":[147],"confocal":[153],"microscopy":[154],"showed":[155],"membrane":[157],"compartmentalization":[158],"these":[160],"subpopulations":[161],"cellular":[164,177],"pool.":[166],"Our":[167],"findings":[168],"offer":[169],"possible":[171],"explanation":[173],"for":[174],"responses":[178],"elicited":[179]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":25},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":23}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}